Follow Us
HIV Treatment and Medical Care

Emtriva (Emtricitabine, FTC)

The Latest

Promo Image

Late 2017 HIV Conferences Focus on Antiretrovirals and Comorbidities

2017 may be winding down, but even as the year wanes, we’ve seen significant new HIV research featured in major scientific conferences in the U.S. and Europe. IDWeek, most recently held in San Diego in early October 2017, is an annual infectious disease...

An Overview of Emtriva (Emtricitabine) Img

An Overview of Emtriva (Emtricitabine)

Brand Name: Emtriva Other Name(s): FTC Drug Class: Nucleoside Reverse Transcriptase Inhibitors

Promo Image

Emtricitabine (Emtriva)

What Is Emtricitabine? Who Should Take Emtricitabine? What About Drug Resistance? How Is Emtricitabine Taken? What Are the Side Effects? How Does Emtricitabine React With Other Drugs?

What Is Emtricitabine?

Emtricitabine (Emtriva) is a ...

Promo Image


Brand name: Emtriva

Generic name: emtricitabine, or FTC

Class: Nucleoside reverse transcriptase inhibitor (nucleoside, NRTI, or nuke)

Manufacturer: Gilead Sciences, Inc.,, (800) GILEAD-5 (445-3235)

AWP: $504.37/month for 200 mg cap...

Promo Image

Emtriva (Emtricitabine)

Emtriva capsules are half light blue and half white. The light-blue half shows the dose (200 mg) and the white half says "Gilead" with the Gilead corporate logo on the left. There is also an oral solution available for Emtriva.

Background and Descri...

Promo Image

FTC (Emtriva) Approved

The U.S. FDA announced the approval of FTC (brand name EmtrivaTM, generic name emtricitabine, former brand name CoviracilTM) on July 2, 2003.

FTC is chemically related to 3TC. It was approved primarily on the basis of two clinical trials: one compar...

Promo Image

U.S. Approves Emtriva; Gilead Hopes Viread/Emtriva Combo Will Compete With Combivir

Gilead Sciences received approval from the US Food and Drug Administration Wednesday for a new once-a-day AIDS drug, Emtriva. Known generically as emtricitabine, Emtriva is a nucleoside reverse transcriptase inhibitor. Gilead now hopes to combine Emt...